1. Challis JRG, Matthews SG, Gibb W, Lye SJ 2000 Endocrine and paracrine
regulation of birth at term and preterm. Endocr Rev 21:514–550
2. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R 1995 A placental
clock controlling the length of human pregnancy. Nat Med 1:460–463
3. Grammatopoulos D, Hillhouse EW 1999 Role of corticotropin-releasing hormone
in the onset of labour. Lancet 353:1546–1549
4. Hillhouse EW, GrammatopoulosD 2001 Control of intracellular signalling by
corticotropin-releasing hormone (CRH) in human myometrium. Front Horm
Res 27:66–74
5. Hillhouse EW, Grammatopoulos D, Milton N, Quartero H 1993 The identification
of a human myometrial corticotropin-releasing hormone receptor
which increases in affinity during pregnancy. J Clin Endocrinol Metab 76:
736–741
6. Aggelidou E, Hillhouse EW, Grammatopoulos DK 2002 Up-regulation of
nitric oxide synthase and modulation of the guanylate cyclase activity by
corticotropin releasing hormone in cultured human pregnant myometrial cells.
Proc Natl Acad Sci USA 99:3300–3305
7. Mignot TM, Paris B, Carbonne B, Vauge C, Ferre F, Vaiman D 2005 Corticotropin-
releasing hormone effects on human pregnant vs. nonpregnant myometrium
explants estimated from a mathematical model of uterine contraction.
J Appl Physiol 99:1157–1163
8. Karteris E, Hillhouse EW, Grammatopoulos DK 2004 Expression of urocortin
II (UCNII) and identification of distinct corticotropin-releasing hormone
type-2 receptor (CRH-R2) signalling pathways regulating myosin light chain
phosphorylation in pregnant myometrial cells. Endocrinology 145:890–900
9. Grammatopoulos D, Hillhouse EW 1999 Activation of protein kinase C by
oxytocin inhibits the biological activity of the human myometrialCRHreceptor
at term. Endocrinology 140:585–594
10. Markovic D, Papadopoulou N, Teli T, Levine MA, Hillhouse EW, Grammatopoulos
DK 2006 Differential responses of CRH receptor type 1 variants
to PKC phosphorylation. J Pharmacol Exp Ther 319:1–11
11. Hillhouse EW, Grammatopoulos DK 2006 The molecular mechanisms underlying
the regulation of the biological activity of corticotropin-releasing
hormone receptors: implications for physiology and pathophysiology. Endocr
Rev 27:260–286
12. Grammatopoulos D, Dai Y, Chen J, Karteris E, Papadopoulou N, Easton AJ,
Hillhouse EW 1998 Human CRH receptor: differences in subtype expression
between pregnant and non-pregnant myometrium. J Clin Endocrinol Metab
83:2539–2544
13. Grammatopoulos D, Dai Y, Randeva HS, Karteris E, Levine MA, Easton AJ,
Hillhouse EW 1999 A novel spliced variant of the type 1 corticotropin-releasing
hormone (CRH) receptor with a deletion in the 7th transmembrane domain
present in the human pregnant term myometrium and fetal membranes. Mol
Endocrinol 13:2189–2202
14. Parham KL, Zervou S, Karteris E, Catalano RD, Old RW, Hillhouse EW 2004
Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor
and regulation by CRF and urocortin. Endocrinology 145:3971–3983
15. Lindstrom TM, Bennett PR 2005 The role of nuclear factor κB in human labour.
Reproduction 130:569–581
16. Belt AR, Baldassare JJ, Molnar M, Romero R, Hertelendy F 1999 The nuclear
transcription factor NF-κB mediates interleukin-1β-induced expression of cyclooxygenase-
2 in human myometrial cells. Am J Obstet Gynecol 181:359–366
17. Bartlett SR, Sawdy R, Mann GE 1999 Induction of cyclooxygenase-2 expression
in human myometrial smooth muscle cells by interleukin-1β: involvement
of p38 mitogen-activated protein kinase. J Physiol 520:399–406
18. Pande V, Ramos MJ 2005 NF-κB in human disease: current inhibitors and
prospects for de novo structure based design of inhibitors. Curr Med Chem
12:357–374
19. Sooranna SR, Engineer N, Loudon JAZ, Terzidou V, Bennett PR, Johnson
MR 2005 The mitogen-activated protein kinase dependent expression of prostaglandin
H synthase-2 and interleukin-8 messenger ribonucleic acid by myometrial
cells: the differential effect of stretch and interleukin-1β. J Clin Endocrinol
Metab 90:3517–3527
20. Grammatopoulos D, Hillhouse EW 1999 Basal and interleukin-1β stimulated
prostaglandin production from cultured human myometrial cells: differential
regulation by corticotropin-releasing hormone. J Clin Endocrinol Metab 84:
2204–2211
21. Grammatopoulos D, Stirrat GM, Williams SA, Hillhouse, EW 1996 The
biological activity of the corticotropin-releasing hormone receptor-adenylate
cyclase complex in human myometrium is reduced at the end of pregnancy.
J Clin Endocrinol Metab 81:745–751
22. Stevens MY, Challis JRG, Lye SJ 1998 Corticotropin-releasing hormone receptor
subtype 1 is significantly up-regulated at the time of labour in the
human myometrium. J Clin Endocrinol Metab 83:4107–4115
23. Pisarchik A, Slominski AT 2001 Alternative splicing of CRH-R1 receptors in
human and mouse skin: identification of new variants and their differential
expression. FASEB J 15:2754–2756
24. Grammatopoulos D, Thompson S, Hillhouse EW 1995 The human myometrium
expresses multiple isoforms of the corticotropin releasing hormone
receptor. J Clin Endocrinol Metab 80:2388–2393
25. Muhle RA, Pavlidis P, Grundy WN, Hirsch E 2001 A high-throughput study
of gene expression in preterm labor with a subtractive microarray approach.
Am J Obstet Gynecol 185:716–724
26. Viatour P, Merville MP, Bours V, Chariot A 2005 Phosphorylation of NF-κB
and IκB proteins: implications in cancer and inflammation. Trends Biochem Sci
30:43–52
27. Soloff MS, Cook Jr DL, Jeng Y-J, Anderson GD 2004 In situ analysis of
interleukin-1-induced transcription of COX-2 and IL-8 in cultured human
myometrial cells. Endocrinology 145:1248–1254
28. Chapman NR, Europe-Finner GN, Robson SC 2004 Expression and deoxyribonucleic
acid-binding activity of the nuclear factor κB family in the human
myometrium during pregnancy and labor. J Clin Endocrinol Metab 89:5683–
5693.
29. Breuiller-Fouche M, Moriniere C, Dallot E, Oger S, Rebourcet R, Cabrol D,
Leroy MJ 2005 Regulation of the endothelin/endothelin receptor system by
interleukin-1β in human myometrial cells. Endocrinology 146:4878–4886
30. Oger S, Mehats C, Dallot E, Ferre F, Leroy MJ 2002 Interleukin-1β induces
phosphodiesterase 4B2 expression in human myometrial cells through a prostaglandin
E2- and cyclic adenosine 3',5'-monophosphate-dependent pathway.
J Clin Endocrinol Metab 87:5524–5531
31. Chapman NR, Smyrnias I, Anumba DO, Europe-Finner GN, Robson SC 2005
Expression of the GTP-binding protein (Gαs) is repressed by the nuclear factor
κB RelA subunit in human myometrium. Endocrinology 146:4994–5002